Australian Pharmaceuticals & Biotech Breakout Stocks

Prescient Therapeutics

Market Cap: AU$77.8m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

Avecho Biotechnology

Market Cap: AU$33.1m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Algorae Pharmaceuticals

Market Cap: AU$25.3m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.